# Allison W. Kurian

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/allison-w-kurian/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,731 |
| Field | BRCA gene mutations in cancer |
| h-index | 77 |
| i10-index | 226 |
| Last Known Institution | Stanford Health Care |
| OpenAlex ID | https://openalex.org/A5067783851 |
| ORCID iD | 0000-0002-6175-9470 |
| Works | 683 |

## Researcher papers

Showing 12 of 15.

- [A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging](https://scholariq.org/papers/a-structured-tumor-immune-microenvironment-in-triple-negative-breast-cancer/)
- [Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/genetic-familial-high-risk-assessment-breast-ovarian-and-pancreatic-version-2/)
- [A Population-Based Study of Genes Previously Implicated in Breast Cancer](https://scholariq.org/papers/a-population-based-study-of-genes-previously-implicated-in-breast-cancer/)
- [NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017](https://scholariq.org/papers/nccn-guidelines-insights-genetic-familial-high-risk-assessment-breast-and/)
- [Genetic/Familial High-Risk Assessment: Breast and Ovarian](https://scholariq.org/papers/genetic-familial-high-risk-assessment-breast-and-ovarian/)
- [Differences in Breast Cancer Survival by Molecular Subtypes in the United States](https://scholariq.org/papers/differences-in-breast-cancer-survival-by-molecular-subtypes-in-the-united-states/)
- [Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines](https://scholariq.org/papers/single-cell-profiling-of-circulating-tumor-cells-transcriptional-heterogeneity/)
- [NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-genetic-familial-high-risk-assessment-breast-ovarian/)
- [Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment](https://scholariq.org/papers/clinical-evaluation-of-a-multiple-gene-sequencing-panel-for-hereditary-cancer/)
- [Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients](https://scholariq.org/papers/genetic-testing-and-results-in-a-population-based-cohort-of-breast-cancer/)
- [Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment](https://scholariq.org/papers/clinical-actionability-of-multigene-panel-testing-for-hereditary-breast-and/)
- [Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012](https://scholariq.org/papers/association-of-screening-and-treatment-with-breast-cancer-mortality-by-molecular/)

## Researcher topics

- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)
- [Cancer Risks and Factors](https://scholariq.org/topics/cancer-risks-and-factors/)
- [Nutrition, Genetics, and Disease](https://scholariq.org/topics/nutrition-genetics-and-disease/)

## Researcher university

- [Stanford Health Care](https://scholariq.org/institutions/stanford-health-care/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
